Stay updated with breaking news from Bcli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group lowered Brainstorm Cell Therapeutics from a buy rating to a hold rating in a research report on Thursday, September […]
StockNews.com began coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report report published on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group lowered shares of Brainstorm Cell Therapeutics from a buy rating to a hold rating in a report on Thursday, September […]
StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a report issued on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group downgraded shares of Brainstorm Cell Therapeutics from a buy rating to a hold rating in a research report on Thursday, September […]
StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note released on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group cut Brainstorm Cell Therapeutics from a buy rating to a hold rating in a research note on Thursday, September 28th. Check […]
By Ben Glickman Shares of Brainstorm Cell Therapeutics were higher Tuesday after the company secured a patent for its technology used for treating ALS. The...